Core points: 1. First, momentum continues to improve at three of APEI's four education units. We're fully staffed, and dedicated and permanent leadership is present. For the full year 2023, we expect revenue growth, EBITDA increases, and margin expansion at APUS, Hondros College of Nursing, and Graduate School USA. 2. Second, 2023 will be a year of rebuilding at Rasmussen University to replenish leade...
アメリカン・パブリック・エデュケーションに関するコメント
TOP WATCH AH + 3/16 ⚡️⚡️
Daily recap 3/15 👍🏼 ALL WINS 🔥 FREE TO JOIN
Current top watch ⚡️⚡️
$Jounce Therapeutics(JNCE.US)$$アメリカン・パブリック・エデュケーション(APEI.US)$$センチネルワン(S.US)$$エレベーション・オンコロジー(ELEV.US)$$ルナイノベーション(LUNA.US)$$リンデ(LIN.US)$$コムキャスト(CMCSA.US)$$HUB Cyber Security(HUBC.US)$$シェル(SHEL.US)$$トゥイリオ(TWLO.US)$
コラムExpert Meeting Minutes | American Public Education, Inc. (APEI) Q4 2022 Earnings Call Transcript
1. First, momentum continues to improve at three of APEI's four education units. We're fully staffed, and dedicated and permanent leadership is present. For the full year 2023, we expect revenue growth, EBITDA increases, and margin expansion at APUS, Hondros College of Nursing, and Graduate School USA.
2. Second, 2023 will be a year of rebuilding at Rasmussen University to replenish leade...
コラムToday's Pre-Market Stock Movers: QCOM, BA, ROKU, AZN and More
In reaction to earnings/guidance:
• $カランプ(CAMP.US)$ +0.6%
Other news:
• $カノ・ヘルス(CANO.US)$ +6.1% ($ヒューマナ(HUM.US)$ in the running to acquire CANO according to WSJ)
• $コーセプト・セラピューティックス(CORT.US)$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPLインベストメント・ホールディングス(LPLA.US)$ +4.1% (reports monthly activity for August)
• $デンツプライ・シロナ(XRAY.US)$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +2.9% (tr...
コラムToday's Pre-Market Stock Movers: TWTR, SOFI, SQ, SBUX and More
In reaction to earnings/guidance:
• $エボリューション・ペトロリアム(EPM.US)$ +9%,$ラディアント・ロジスティクス(RLGT.US)$ +5.3%,$BRP(DOOO.US)$ +1.4%,$グースヘッド・インシュアランス(GSHD.US)$ +1%,$アシュランド(ASH.US)$ +0.9%,$RTXコーポレーション(RTX.US)$ +0.7%
Other news:
• $Delwinds Insurance(DWIN.US)$ +18.5% (announces forward purchase agreement and amended backstop agreements)
• $NGM Biopharmaceuticals(NGM.US)$ +6.1% (provides preliminary findings for Pha...
まだコメントはありません